Literature DB >> 6847909

The recurrence of intracranial meningiomas after surgical treatment.

A B Adegbite, M I Khan, K W Paine, L K Tan.   

Abstract

A study of 114 surgically treated patients with intracranial meningiomas was carried out to evaluate factors influencing recurrence. The data of the initial surgery extended over a 24-year period from January, 1956, to December, 1979. The patients ranged in age from 1 1/2 years to 82 years. Seventy-one (62.3%) were females and 43 (37.7%) were males. The surgical procedure was graded according to Simpson's classification from 1 to 5 (Grade 1 = complete excision, Grade 5 = simple decompression). In this series, 33 procedures (28.9%) were Grade 1, 55 (48.2%) were Grade 2, seven (6.1%) were Grade 3, 18 (15.8%) were Grade 4, and one (0.9%) was Grade 5. There were eight (7%) postoperative deaths. Approximately 60% of the tumors were located in the sphenoid wing (23.7%), convexity (21.1%), and parasagittally (14.9%). Histological diagnosis in 96% of the patients was transitional (42.1%), syncytial (34.2%), and fibroblastic (20.2%) meningiomas. Eight (7%) patients received postoperative radiotherapy. There was evidence of recurrence in 22 patients (19.3%). Twenty-one underwent a second surgical procedure. Using survival analysis, it was determined that 80% of the patients were free of recurrence 5 years after the initial surgery, and approximately 50% showed no recurrence 20 years after the initial surgery. Only the grade of the initial surgery had a statistically significant influence on recurrence. Sex of patients, site and histology of the tumor, and postoperative radiotherapy had no statistically significant influence on recurrence. Angioblastic and malignant meningiomas were rare (only four cases), and recurred relatively quickly.

Entities:  

Mesh:

Year:  1983        PMID: 6847909     DOI: 10.3171/jns.1983.58.1.0051

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  90 in total

Review 1.  Tumors of the meninges: proposed modifications of the World Health Organization classification.

Authors:  B W Scheithauer
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Impaired survival and long-term neurological problems in benign meningioma.

Authors:  Hanna van Alkemade; Michelle de Leau; Edith M T Dieleman; Jan W P F Kardaun; Rob van Os; W Peter Vandertop; Wouter R van Furth; Lukas J A Stalpers
Journal:  Neuro Oncol       Date:  2012-03-09       Impact factor: 12.300

Review 3.  Fractionated radiotherapy for intracranial meningiomas.

Authors:  Vinai Gondi; Wolfgang A Tome; Minesh P Mehta
Journal:  J Neurooncol       Date:  2010-09-01       Impact factor: 4.130

4.  No prediction of recurrence of meningiomas by PCNA and Ki-67 immunohistochemistry.

Authors:  M L Møller; O Braendstrup
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

5.  Factors influencing meningioma recurrence rate.

Authors:  M Naumann; J Meixensberger
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

6.  Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors.

Authors:  Francesco Maiuri; Marialaura Del Basso De Caro; Felice Esposito; Paolo Cappabianca; Viviana Strazzullo; Guido Pettinato; Enrico de Divitiis
Journal:  J Neurooncol       Date:  2007-01-17       Impact factor: 4.130

7.  Hyperdiploidy defines a distinct cytogenetic entity of meningiomas.

Authors:  Ralf Ketter; Yoo-Jin Kim; Simone Storck; Jörg Rahnenführer; Bernd F M Romeike; Wolf-Ingo Steudel; Klaus D Zang; Wolfram Henn
Journal:  J Neurooncol       Date:  2007-01-17       Impact factor: 4.130

8.  Meningiomas: skull base versus non-skull base.

Authors:  Torstein R Meling; Michele Da Broi; David Scheie; Eirik Helseth
Journal:  Neurosurg Rev       Date:  2018-04-07       Impact factor: 3.042

9.  Proliferative potential of meningiomas evaluated by proliferating cell nuclear antigen expression.

Authors:  H Nakabayashi; M Sakaguchi; J Katsuyama; A Hakuba
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

10.  Expression of RACGAP1 in high grade meningiomas: a potential role in cancer progression.

Authors:  Hong-Lin Ke; Rong-Hu Ke; Shi-Ting Li; Bin Li; Hai-Tao Lu; Xiao-Qiang Wang
Journal:  J Neurooncol       Date:  2013-03-25       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.